Home
Stiri si Evenimente

Arrhythmia Alliance News & Events

All News

The World Stroke Congress 2018 is hosting a symposium with a panel of experts to discuss Atrial Fibrillation and various ways to advance policies and advocacy initiatives that can help reduce the risk of AF-related stroke.

16 October 2018 For PatientsFor Clinicians

Our very own Trudie Lobaan will be presenting - Read more to tune in tomorrow at 13:00h EST - 18:00h BST.

Read more [links to external site]

October Patient e-News 2018

5 October 2018 E-newsFor Patients

Get all the latest from us for this month and register for Patients Day 2018!

Read more [links to external site]

Making promises for all our hearts

www.jnjmedicaldevices.com, 1 October 2018 Defibs Save LivesFor PatientsFor Clinicians

World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease. The annual campaign brings together individuals, families, communities and organisations around the world to participate in activities to take charge of their heart health and that of others. This year’s theme for World Heart Day is to make a promise... for my heart, for your heart, for all our hearts.

Read more [links to external site]

We’re supporting the Cardiovascular Health campaign with Media Planet UK

1 October 2018 For PatientsFor Clinicians

A Mother’s Mission to Educate the World About Arrhythmia

www.futureofpersonalhealth.com, 1 October 2018 Defibs Save LivesFor PatientsFor Clinicians

When Trudie Lobban’s daughter Francesca, now 29, was a baby, the girl had fainting episodes up to eight times a day. It took three years until Francesca was diagnosed with Reflex Anoxic Seizures (RAS), a condition that caused her heart to briefly stop.

Read more [links to external site]

Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*

venicearrhythmias.org, 21 September 2018 For Clinicians

wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).

Read more [links to external site]